Request Deal Involvement
Goldman Sachs Alternatives led a $115m Series B round in Triveni Bio.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Latham & Watkins
or
Principals
target
TRIVENI BIO
bidder
ORBIMED PE
bidder
DEEP TRACK CAPITAL
bidder
CORMORANT ASSET MANAGEMENT
bidder
GOLDMAN SACHS ALTERNATIVES
bidder
FIDELITY MANAGEMENT & RESEARCH COMPANY
bidder
ATLAS VENTURE LP
bidder
VIKING GLOBAL INVESTORS
bidder
THE INVUS GROUP LLC
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite